Sargent Bickham Lagudis’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-182
| Closed | -$9K | – | 784 |
|
|
2020
Q1 | $9K | Hold |
182
| – | – | ﹤0.01% | 566 |
|
|
2019
Q4 | $11K | Hold |
182
| – | – | ﹤0.01% | 603 |
|
|
2019
Q3 | $10K | Hold |
182
| – | – | ﹤0.01% | 561 |
|
|
2019
Q2 | $9K | Sell |
182
-421
| -70% | -$20.8K | ﹤0.01% | 599 |
|
|
2019
Q1 | $32K | Sell |
603
-77
| -11% | -$4.09K | ﹤0.01% | 449 |
|
|
2018
Q4 | $32K | Buy |
680
+188
| +38% | +$8.85K | ﹤0.01% | 422 |
|
|
2018
Q3 | $25K | Buy |
492
+6
| +1% | +$305 | ﹤0.01% | 460 |
|
|
2018
Q2 | $25K | Buy |
486
+6
| +1% | +$309 | ﹤0.01% | 458 |
|
|
2018
Q1 | $23K | Buy |
480
+400
| +500% | +$19.2K | ﹤0.01% | 458 |
|
|
2017
Q4 | $4K | Sell |
80
-400
| -83% | -$20K | ﹤0.01% | 700 |
|
|
2017
Q3 | $24K | Hold |
480
| – | – | ﹤0.01% | 471 |
|
|
2017
Q2 | $26K | Hold |
480
| – | – | ﹤0.01% | 446 |
|
|
2017
Q1 | $25K | Hold |
480
| – | – | ﹤0.01% | 456 |
|
|
2016
Q4 | $23K | Sell |
480
-299
| -38% | -$14.3K | ﹤0.01% | 443 |
|
|
2016
Q3 | $42 | Buy |
779
+193
| +33% | +$10 | 0.01% | 375 |
|
|
2016
Q2 | $32K | Buy |
586
+312
| +114% | +$17K | 0.01% | 397 |
|
|
2016
Q1 | $14K | Buy |
+274
| New | +$14K | ﹤0.01% | 523 |
|